VANCOUVER, Washington, Feb. 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that it will be presenting a company overview at BIO CEO & Investor Conference 2019 on Monday, February 11, at 9:45 a.m. Eastern time (6:45 a.m. Pacific time).  The conference is being held at the Marriott Marquis Hotel in New York City.

The BIO CEO & Investor Conference is an international biotech investor conference focused on established and emerging publicly traded and select private biotech companies.  More information regarding the conference can be found at https://www.bio.org/events/bio-ceo-investor-conference.

The presentation by CytoDyn management is Monday, February 11, at 9:45 a.m. ET.  A live webcast and replay of the presentation at BIO CEO will be available on the Investors section of the Company’s website, http://ir.cytodyn.com/. The webcast will be available approximately one hour after the webcast presentation ends and will be accessible for 90 days.

CONTACTS

Investors:
Nader Pourhassan, Ph.D.
President & CEO
360-980-8524
npourhassan@cytodyn.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.